Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Cutaneous Sarcoidosis. Clin Chest Med 2015 Dec;36(4):685-702

Date

11/26/2015

Pubmed ID

26593142

DOI

10.1016/j.ccm.2015.08.010

Scopus ID

2-s2.0-84947744928 (requires institutional sign-in at Scopus site)   91 Citations

Abstract

The skin is the second most common organ affected in sarcoidosis, which can affect patients of all ages and races, with African American women having the highest rates of sarcoidosis in the United States. The cutaneous manifestations are protean and can reflect involvement of sarcoidal granulomas within the lesion or represent reactive non-specific inflammation, as seen with erythema nodosum. Systemic work-up is necessary in any patient with cutaneous involvement of sarcoidal granulomas, and treatment depends on other organ involvement and severity of clinical disease. Skin-directed therapies are first line for mild disease, and immunomodulators or immunosuppressants may be necessary.

Author List

Wanat KA, Rosenbach M

Author

Karolyn A. Wanat MD Chair, Professor in the Dermatology department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Granuloma
Humans
Immunosuppressive Agents
Inflammation
Sarcoidosis
Skin Diseases